Top

Published in:

01-02-2013 | Case Report

Pulmonary Interstitial Glycogenosis Associated With Pulmonary Hypertension and Hypertrophic Cardiomyopathy

Authors: Abdullah Alkhorayyef, Lindsay Ryerson, Alicia Chan, Ernest Phillipos, Atilano Lacson, Ian Adatia

Published in: Pediatric Cardiology | Issue 2/2013

Abstract

A neonate with pulmonary interstitial glycogenosis, pulmonary hypertension, and hypertrophic cardiomyopathy is described. The fatal outcome for this patient contrasts with the reported favorable prognosis associated with isolated pulmonary interstitial glycogenosis. To the authors’ knowledge, the association of pulmonary interstitial glycogenosis and hypertrophic cardiomyopathy has not been reported previously. The authors have broadened the phenotype of pulmonary interstitial glycogenosis and demonstrate the diagnostic value of lung biopsy in cases of unexplained neonatal pulmonary hypertension.

Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, Kanter RJ, Rice H, Chen YT, Kishnani PS (2006) Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 8:297–301. doi:10.1097/01.gim.0000195896.04069.5f PubMedCrossRef

Breitweser JA, Meyer RA, Sperling MA, Tsang RC, Kaplan S (1980) Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr 96(3 Pt 2):535–539PubMed

Canakis AM, Cutz E, Manson D, O’Brodovich H (2002) Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med 165:1557–1565PubMedCrossRef

Castillo M, Vade A, Lim-Dunham JE, Masuda E, Massarani-Wafai R (2010) Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation. Pediatr Radiol 40:1562–1565. doi:10.1007/s00247-010-1670-2 PubMedCrossRef

Deutsch GH, Young LR (2009) Histologic resolution of pulmonary interstitial glycogenosis. Pediatr Dev Pathol 12:475–480. doi:10.2350/08-12-0575.1 PubMedCrossRef

Deutsch GH, Young LR (2010) Pulmonary interstitial glycogenosis: words of caution. Pediatr Radiol 40:1471–1475. doi:10.1007/s00247-010-1730-7 PubMedCrossRef

Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, Albright EA, Askin FB, Baker P, Chou PM, Cool CM, Coventry SC, Cutz E, Davis MM, Dishop MK, Galambos C, Patterson K, Travis WD, Wert SE, White FV (2007) Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 176:1120–1128. doi:10.1164/rccm.200703-393OC PubMedCrossRef

Dinwiddie R, Sharief N, Crawford O (2002) Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol 34:23–29. doi:10.1002/ppul.10125 PubMedCrossRef

Dworzak F, Casazza F, Mora M, De Maria R, Gronda E, Baroldi G, Rimoldi M, Morandi L, Cornelio F (1994) Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant. Neuromuscul Disord 4:243–247PubMedCrossRef

10.

Faienza MF, Giordani L, Ferraris M, Bona G, Cavallo L (2009) PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link? Pediatr Cardiol 30:1012–1015. doi:10.1007/s00246-009-9473-7 PubMedCrossRef

11.

Fan LL, Kozinetz CA (1997) Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med 156(3 Pt 1):939–942PubMed

12.

Israel BA, Sherman FS, Guthrie RD (1993) Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol 10:307–310. doi:10.1055/s-2007-994747 PubMedCrossRef

13.

Lanfranchi M, Allbery SM, Wheelock L, Perry D (2010) Pulmonary interstitial glycogenosis. Pediatr Radiol 40:361–365. doi:10.1007/s00247-009-1455-7 PubMedCrossRef

14.

Nishikawa T, Ishiyama S, Shimojo T, Takeda K, Kasajima T, Momma K (1996) Hypertrophic cardiomyopathy in Noonan syndrome. Acta Paediatr Jpn 38:91–98PubMedCrossRef

15.

Onland W, Molenaar JJ, Leguit RJ, van Nierop JC, Noorduyn LA, van Rijn RR, Geukers VG (2005) Pulmonary interstitial glycogenosis in identical twins. Pediatr Pulmonol 40:362–366. doi:10.1002/ppul.20255 PubMedCrossRef

16.

Schroeder SA, Shannon DC, Mark EJ (1992) Cellular interstitial pneumonitis in infants: a clinicopathologic study. Chest 101:1065–1069PubMedCrossRef

17.

Sengers RC, Stadhouders AM, van Lakwijk-Vondrovicova E, Kubat K, Ruitenbeek W (1985) Hypertrophic cardiomyopathy associated with a mitochondrial myopathy of voluntary muscles and congenital cataract. Br Heart J 54:543–547PubMedCrossRef

18.

Smets K, Van Daele S (2011) Neonatal pulmonary interstitial glycogenosis in a patient with Hunter syndrome. Eur J Pediatr 170:1083–1084. doi:10.1007/s00431-011-1444-3 PubMedCrossRef

19.

Smets K, Dhaene K, Schelstraete P, Meersschaut V, Vanhaesebrouck P (2004) Neonatal pulmonary interstitial glycogen accumulation disorder. Eur J Pediatr 163:408–409. doi:10.1007/s00431-004-1450-9 PubMedCrossRef

20.

Tomita H, Fuse S, Ikeda K, Matsuda K, Chiba S (1998) An infant with Costello syndrome complicated with fatal hypertrophic obstructive cardiomyopathy. Acta Paediatr Jpn 40:608–611PubMedCrossRef

21.

Vaillant MC, Chantepie A, Casasoprana A, Chamboux C, Suc AL, Gold F, Laugier J (1997) Transient hypertrophic cardiomyopathy in neonates after acute fetal distress. Pediatr Cardiol 18:52–56PubMedCrossRef

22.

van der Ploeg AT, Reuser AJ (2008) Pompe’s disease. Lancet 372:1342–1353. doi:10.1016/S0140-6736(08)61555-X PubMedCrossRef

23.

Wadhawan R, Khanna P, Nora F, Gilbert-Barness E (2008) Clinicopathologic conference: persistent tachypnea in a 5-week-old boy. Fetal Pediatr Pathol 27:185–196. doi:10.1080/15513810802319343 PubMedCrossRef

24.

Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120(2 Pt 1):286–291PubMed

Title: Pulmonary Interstitial Glycogenosis Associated With Pulmonary Hypertension and Hypertrophic Cardiomyopathy
Authors: Abdullah Alkhorayyef
Lindsay Ryerson
Alicia Chan
Ernest Phillipos
Atilano Lacson
Ian Adatia
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Pediatric Cardiology / Issue 2/2013
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-012-0311-y

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Pulmonary Interstitial Glycogenosis Associated With Pulmonary Hypertension and Hypertrophic Cardiomyopathy

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Aortic Aneurysms Remain a Significant Source of Morbidity and Mortality After Use of Dacron® Patch Aortoplasty to Repair Coarctation of the Aorta: Results from a Single Center

A Multi-institutional Analysis of Inpatient Treatment for Supraventricular Tachycardia in Newborns and Infants

Descending Aortic Aneurysm Associated With Coarctation

Quantitative Ultrasound Measurement of Intima–Media Thickness of Abdominal Aorta and Common Carotid Arteries in Normal Term Newborns

Beneficial Effects of Residual Right Ventricular Outflow Tract Obstruction on Right Ventricular Volume and Function in Patients After Repair of Tetralogy of Fallot

Prolonged Electrical Quiescence After Direct Current Cardioversion for Atrial Flutter in Congenital Heart Disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page